Scientific News Cytokinetics Announces Upcoming Presentations At The Hcms Scientific Sessions And The Hfsa Annual Scientific Meeting
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Cytokinetics Announces Upcoming Presentations At The Hcms Scientific Sessions And The Hfsa Annual Scientific Meeting is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025
Long-Term Data from FOREST-HCM in Non-Obstructive HCM and Results from Prespecified Analysis of MAPLE-HCM to be Presented in Late-Breaking Clinical Research Session SOUTH SAN FRANCISCO, Calif., Sept. Read More
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximal and Submaximal Exercise Capacity and Recovery Compared to Metoprolol 96-Week Analyses from FOREST-HCM Support ... Read More
Cytokinetics Announces Upcoming Presentations at the 2023 HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Cytokinetics disclaims any intent or obligation to update these ... Read More
Cytokinetics Announces Three Upcoming Presentations at the HFSA Annual Scientific Meeting 2025
Long-Term Data from FOREST-HCM in Non-Obstructive HCM and Results from Prespecified Analysis of MAPLE-HCM to be Presented in Late-Breaking Clinical Research Session ... Read More
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
Long-Term Efficacy and Tolerability of Aficamten in Patients with Non-Obstructive HCM Pre-Specified Analysis of Supplemental Endpoints from MAPLE-HCM Shows Aficamten Improves Measures of Submaximal ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus